Lawrence O. Klein
2019
In 2019, Lawrence O. Klein earned a total compensation of $6.1M as Chief Business Officer and Chief Operating Officer at CRISPR Therapeutics AG.
Compensation breakdown
| Non-Equity Incentive Plan | $209,032 |
|---|---|
| Option Awards | $1,549,003 |
| Salary | $360,400 |
| Stock Awards | $3,984,600 |
| Other | $9,800 |
| Total | $6,112,835 |
Klein received $4M in stock awards, accounting for 65% of the total pay in 2019.
Klein also received $209K in non-equity incentive plan, $1.5M in option awards, $360.4K in salary and $9.8K in other compensation.
Rankings
In 2019, Lawrence O. Klein's compensation ranked 1,658th out of 13,971 executives tracked by ExecPay. In other words, Klein earned more than 88.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,658 out of 13,971 | 88th |
Division Manufacturing | 592 out of 5,695 | 90th |
Major group Chemicals And Allied Products | 179 out of 2,194 | 92nd |
Industry group Drugs | 144 out of 1,880 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 33 out of 389 | 92nd |
Source: SEC filing on April 24, 2020.
Klein's colleagues
We found four more compensation records of executives who worked with Lawrence O. Klein at CRISPR Therapeutics AG in 2019.